Internal + Extramural
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
External | Non-Limited Opportunities
National Cancer Institute (NCI)
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
Application: 11/17/2022
Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
Application: 9/30/2022
National Institutes of Health (NIH)
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
Application: 9/8/2022
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) Application: 9/8/2022
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
Application: 10/5/2022; 2/5/2023; 6/5/2023
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
Application: 10/5/2022; 2/5/2023; 6/5/2023
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
Application: 10/27/2022; 7/27/2023
Peer Reviewed Agencies
Florida Biomedical Research Program
Bankhead Coley Cancer Research Program
Application: 8/10/2022
James and Esther King Biomedical Research Program
Application: 8/10/2022
Live Like Bella Pediatric Cancer Research Initiative
Application: 8/10/2022
Please send a copy of your submitted LOI to the UFHCC Office of Research Administration at ResearchAdmin@cancer.ufl.edu for internal tracking and coordination.
Howard Hughes Medical Institute
Freeman Hrabowski Scholars Program
Application: 9/28/2022
Melanoma Research Foundation
Mid-Career Bridge Grant Request for Proposals (RFP)
Application: 8/15/2022; 12/15/2022
Non-Peer Reviewed Agencies
Cholangiocarcinoma Foundation
2023 Research Fellowship Awards
Required LOI: 8/12/2022
Application: 9/23/2022
St. Baldrick’s Foundation
Research Grants in Burkitt lymphoma, Ewing sarcoma, rhabdoid tumors (liver), childhood glioblastoma multiforme (GBM), and atypical teratoid rhabdoid tumor (ATRT)
Application: 8/26/2022
Johnson & Johnson
Innovations for Vets QuickFire Challenge Lung Cancer & Physical Trauma
Application: 8/12/2022
Other External
Diversity, equity, and inclusion funding opportunities
Cancer Research Foundation
Postdoctoral Fellowship to Promote Racial Diversity
Deadline: 9/1/22
National Cancer Institute (NCI)
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Deadline: 9/6/22
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
Deadline: 10/12/22
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
Deadline: 10/12/22
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
Deadline: 10/12/22
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
Deadline: 10/12/22
Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
Deadline: Dependent upon mechanism
Notice of Special Interest: Alcohol and Cancer Control
Deadline: Dependent upon mechanism
National Institutes of Health (NIH)
T32 Training Program for Institutions That Promote Diversity (T32 – Clinical Trial Not Allowed)
Deadline: 9/13/22
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed)
LOI: 9/21/22; Application: 10/21/22
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)
Deadline: 10/5/22
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
Deadline: 10/13/22
Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 – Clinical Trials Optional)
Deadline: 11/13/22
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
Deadline: 11/17/22
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
Deadline: 1/26/23
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
Deadline: 2/5/23
Notice of Special Interest: NIDCD Health Disparities and Inequities Research
Deadline: Dependent upon mechanism
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
Deadline: Dependent upon mechanism
Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
Deadline: Dependent upon mechanism
American Society of Clinical Oncology (ASCO)
Advanced Clinical Research Award (ACRA) for Diversity and Inclusion
Deadlines: 12/14/22 | 1/31/23